Cargando…

Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial

BACKGROUND: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining quest...

Descripción completa

Detalles Bibliográficos
Autores principales: van Bastelaar, Kim MP, Pouwer, François, Cuijpers, Pim, Riper, Heleen, Twisk, Jos WR, Snoek, Frank J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Gunther Eysenbach 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846344/
https://www.ncbi.nlm.nih.gov/pubmed/22262728
http://dx.doi.org/10.2196/jmir.1657
_version_ 1782293417975349248
author van Bastelaar, Kim MP
Pouwer, François
Cuijpers, Pim
Riper, Heleen
Twisk, Jos WR
Snoek, Frank J
author_facet van Bastelaar, Kim MP
Pouwer, François
Cuijpers, Pim
Riper, Heleen
Twisk, Jos WR
Snoek, Frank J
author_sort van Bastelaar, Kim MP
collection PubMed
description BACKGROUND: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. OBJECTIVE: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). METHODS: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008–2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. RESULTS: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. CONCLUSIONS: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile. CLINICALTRIAL: International Standard Randomized Controlled Trial Number (ISRCTN): 24874457; http://www.controlled-trials.com/ISRCTN24874457 (Archived by WebCite at http://www.webcitation.org/63hwdviYr)
format Online
Article
Text
id pubmed-3846344
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Gunther Eysenbach
record_format MEDLINE/PubMed
spelling pubmed-38463442013-12-03 Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial van Bastelaar, Kim MP Pouwer, François Cuijpers, Pim Riper, Heleen Twisk, Jos WR Snoek, Frank J J Med Internet Res Original Paper BACKGROUND: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. OBJECTIVE: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). METHODS: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008–2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. RESULTS: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. CONCLUSIONS: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile. CLINICALTRIAL: International Standard Randomized Controlled Trial Number (ISRCTN): 24874457; http://www.controlled-trials.com/ISRCTN24874457 (Archived by WebCite at http://www.webcitation.org/63hwdviYr) Gunther Eysenbach 2012-01-05 /pmc/articles/PMC3846344/ /pubmed/22262728 http://dx.doi.org/10.2196/jmir.1657 Text en ©Kim MP van Bastelaar, François Pouwer, Pim Cuijpers, Heleen Riper, Jos WR Twisk, Frank J Snoek. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 05.01.2012. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
van Bastelaar, Kim MP
Pouwer, François
Cuijpers, Pim
Riper, Heleen
Twisk, Jos WR
Snoek, Frank J
Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
title Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
title_full Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
title_fullStr Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
title_full_unstemmed Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
title_short Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
title_sort is a severe clinical profile an effect modifier in a web-based depression treatment for adults with type 1 or type 2 diabetes? secondary analyses from a randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846344/
https://www.ncbi.nlm.nih.gov/pubmed/22262728
http://dx.doi.org/10.2196/jmir.1657
work_keys_str_mv AT vanbastelaarkimmp isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial
AT pouwerfrancois isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial
AT cuijperspim isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial
AT riperheleen isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial
AT twiskjoswr isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial
AT snoekfrankj isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial